As Aβ is the key molecule leading to neurodegeneration in AD (Scheltens et al., 2021), we analyzed the effects of myeloid p38α‐MAPK on Aβ pathology in the APP‐transgenic mice. The gene discussed is APP; the disease is Alzheimer disease.